Abstract: A driver and a control valve are provided. The control valve includes a valve body, a first valve core and a second valve core. The valve body provided with a valve cavity. A side wall of the valve body is provided with a plurality of communicating holes, and the communicating hole penetrates through the side wall of the valve body and is in communicate with the valve cavity. The first valve core is rotatably disposed at one end of the valve cavity, the first valve core is provided with a plurality of first passages and a plurality of second passages on a circumferential side of the first valve core. The second valve core is rotatably disposed at the other end of the valve cavity, and the second valve core is coaxially disposed with the first valve core, and the second valve core is coaxially disposed with the first valve core.

Abstract: A gas-liquid separator and an air conditioning device are provided. The gas-liquid separator includes a shell, an air outlet pipe, a filter member, and a fixed frame. The shell is provided with a liquid storage chamber. The air outlet pipe is at least partially disposed in the liquid storage chamber, and a portion of the air outlet pipe located in the liquid storage chamber is provided with a filter port. The filter member is fixedly connected to the filter port of the air outlet pipe to filter medium entering the air outlet pipe from the filter port. The fixed frame is fixedly connected to the shell and the filter member.

Abstract: A conjugate compounds or pharmaceutically acceptable salt thereof, comprises a payload and two or more kinds of cell-interacting molecules. The cell-interacting molecules are ligands capable of specifically binding to a cell surface receptor. A method of treating diseases, comprises delivering a payload to a subject.

Abstract: A valve device is provided, including a valve body unit and a valve seat. The valve seat is provided with a mounting cavity, and an end of the valve body unit is mounted in the mounting cavity. The valve device further includes a limiting unit, an outer side wall of the valve seat is provided with a mounting hole in communication with the mounting cavity along a radial direction of the mounting cavity, a side wall of the mounting cavity is recessed to form a mounting groove corresponding to the mounting hole, an end of the limiting unit extends into the mounting cavity from the mounting hole and is inserted into the mounting groove, and the limiting unit that extends into the mounting cavity abuts against the valve body unit to perform limiting along an axial direction and a circumferential direction between the valve body unit and the valve seat.

Abstract: A check valve is provided. The check valve includes a valve body and a piston unit. The valve body includes a valve cavity and a valve port. The valve body is provided with an inlet and an outlet. The valve port is located between the inlet and the valve cavity. The outlet is in communication with the valve cavity. The piston unit is capable of moving in the valve cavity along an axis of the valve body to open/close the valve port. The valve cavity includes a flaring portion. Along the axis of the valve body, a flow area of a cross section of the flaring portion is greater than a flow area of a cross section of the valve port.

Abstract: A display device includes: a display screen including a display screen body and a display screen edge part, at least one edge of the display screen being bent toward a back side of the display screen to form the display screen body and the display screen edge part; a first light sensor arranged on a back side of the display screen body and configured to detect a brightness of ambient light of a front side of the display screen body; a light source arranged on a front side of the display screen edge part and configured to emit light according to a preset brightness; and a second light sensor arranged on a back side of the display screen edge part and configured to detect a brightness of the light source.

Abstract: The present disclosure provides an in vitro proliferation medium, an in vitro culture kit and an in vitro proliferation culture method of umbilical cord blood (UCB)-derived natural killer (NK) cells, and relates to the technical field of cell in vitro culture. In the present disclosure, the in vitro proliferation medium does not include animal serum to reduce immune responses when being used, with better safety. The in vitro proliferation medium is used to proliferate the UCB-derived NK cells in vitro, with simple and easy operations and low cost, and without coating, sorting and trophoblast cells. The medium does not include animal-derived ingredients, and has desirable safety and stability. The medium can be used for direct culture of peripheral blood mononuclear cells (PBMCs) isolated by Ficoll, and harvest more NK cells that meet clinical use standards.

Abstract: A conjugate compounds or pharmaceutically acceptable salt thereof, comprises a payload and two or more kinds of cell-interacting molecules. The cell-interacting molecules are ligands capable of specifically binding to a cell surface receptor. A method of treating diseases, comprises delivering a payload to a subject.

Abstract: The present disclosure discloses a conjugate compound or a pharmaceutically acceptable salt thereof, comprising a payload and two targeting molecules. Further disclosed herein is a pharmaceutical composition, comprising the conjugate compound or the pharmaceutically acceptable salt thereof. The present disclosure additionally relates to a method for delivering a payload to a subject in need thereof, and a method for treating a disease, wherein the methods comprise administering to the subject a therapeutically effective amount of the conjugate compound or the pharmaceutically acceptable salt thereof, or the pharmaceutical composition as disclosed herein.

Abstract: A transformer core for a dry-type transformer includes a laminated construction having several groups of stacked laminations that form a step-lap sequence of laminations. Each group in the step-lap sequence has a mean length different than an adjacent group in the step-lap sequence and has at least two identical laminations per group, wherein at least one group has at least four identical laminations. Methods of assembling a transformer core are also provided, as are other aspects.

Abstract: A transformer core for a dry-type transformer includes a laminated construction having several groups of stacked laminations that form a step-lap sequence of laminations. Each group in the step-lap sequence has a mean length different than an adjacent group in the step-lap sequence and has at least two identical laminations per group, wherein at least one group has at least four identical laminations. Methods of assembling a transformer core are also provided, as are other aspects.

Abstract: A conjugate compounds or pharmaceutically acceptable salt thereof, comprises a payload and two or more kinds of cell-interacting molecules. The cell-interacting molecules are ligands capable of specifically binding to a cell surface receptor. A method of treating diseases, comprises delivering a payload to a subject.